Targeting PPARα activation sensitizes glioblastoma cells to temozolomide and reverses acquired resistance by inhibiting H3K18 lactylation. - Wang ZC; Li C; Zhang Z; Lu S; Liu YM; Qi P; Chen X; Wang YB; Feng WJ; Pan CL; Wang QX; Ji ZL; et al. (Acta pharmacologica Sinica, 2025)